Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
NCT04359706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2022-10-17
Summary
Observational pilot single-center study aiming to determine the microbiota of critically ill patients infected with SARS-CoV-2. COVID-19 patients will be compared to historical critically ill controls with no SARS-CoV-2 infection.
Conditions
- Sars-CoV2
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Saad Nseir, MD,PhD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-08
- Primary Completion
- 2020-10-23
- Completion
- 2020-10-23
Countries
- France
Study Locations
More Related Trials
-
Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients
NCT04669938 ·Status: UNKNOWN
-
Characterization of Respiratory Microbiota in Susceptibility to Viral Respiratory Infections
NCT03600753 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Analysis of Pulmonary Microbiome in Intubated Patients
NCT03720093 ·Status: COMPLETED
-
Co-infection Management in COVID-19 Critically Ill
NCT04382092 ·Status: COMPLETED ·Phase: NA
-
Pathogenic Microorganisms in Adult Severe Pneumonia Patients
NCT04433403 ·Status: UNKNOWN
-
Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure
NCT03379779 ·Status: COMPLETED
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
An Antibiotic Protocol Guided by a Multimodal Approach in AECOPD With Pneumonia in Intensive Care
NCT06301841 ·Status: RECRUITING ·Phase: NA
-
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481 ·Status: RECRUITING
-
The Association Mechanism Between the Microbiome and the Development of Community Pneumonia Was Studied Based on the Analysis of Pulmonary Microbiota - Host Interaction Network
NCT06896019 ·Status: ACTIVE_NOT_RECRUITING
-
Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis
NCT06977165 ·Status: NOT_YET_RECRUITING
-
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
NCT04453540 ·Status: UNKNOWN
-
Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia
NCT02276092 ·Status: COMPLETED
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
NCT04488510 ·Status: UNKNOWN
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
Clinical Trial Assessing the Value of an Antibiotic Protocol Guided by Serum Procalcitonin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Intensive Care
NCT02521636 ·Status: UNKNOWN ·Phase: NA
-
Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19
NCT04505631 ·Status: COMPLETED
-
Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
NCT04522076 ·Status: ACTIVE_NOT_RECRUITING
-
ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD
NCT00190437 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia
NCT03452826 ·Status: COMPLETED ·Phase: NA
-
Drug Resistance Factors In Healthcare-associated Pneumonia
NCT02736097 ·Status: COMPLETED
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN
-
Usefulness of Microbiological Tests in Community-Acquired Pneumonia
NCT00312741 ·Status: UNKNOWN